Organamet Bio’s Mission
Our mission is to save lives through increased availability of hearts.
Our goal is to make bioengineered personalized human hearts available within 5 years.
Organamet Bio’s Mission
Our mission is to save lives through increased availability of hearts.
Our goal is to make bioengineered personalized human hearts available within 5 years.
NOW:
- ARMI-BioFab USA Partnership Yielded Scaled Modular Automated and Closed Manufacturing Process Development
- Supply Chain and Manufacturing Partners Identified
NEXT:
- Scale Up Manufacturing
- IND-enabling Studies
- First in Human Transplant
NOW:
- ARMI-BioFab USA Partnership Yielded Scaled Modular Automated and Closed Manufacturing Process Development
- Supply Chain and Manufacturing Partners Identified
NEXT:
- Scale Up Manufacturing
- IND-enabling Studies
- First in Human Transplant
- Proven Bioengineered Heart Technology at an Inflection Point
- Led by Technology Inventor/Founder of Public Company
- Backed by Seasoned Scientific, Medical, and Business Teams (CFO, CMO, CCO, CIO, law firm)
- Intellectual Property – Trade Secrets/Know-How/Patents
- Strategic Government Academic and Corporate Partners
- Deep Scientific Bench
- Milestone Driven Roadmap to Value
- Opportunities for Revenue/ROI beginning in Y3
- Access to TAM – $22B with $19.5% CAGR
- Proven Bioengineered Heart Technology at an Inflection Point
- Led by Technology Inventor/Founder of Public Company
- Backed by Seasoned Scientific, Medical, and Business Teams (CFO, CMO, CCO, CIO, law firm)
- Intellectual Property – Trade Secrets/Know-How/Patents
- Strategic Government Academic and Corporate Partners
- Deep Scientific Bench
- Milestone Driven Roadmap to Value
- Opportunities for Revenue/ROI beginning in Y3
- Access to TAM – $22B with $19.5% CAGR
“In our line of work, someone has to die for someone else to live.”
Trusted Partners
Organamet Bio has established a network of partners to develop its technology and is looking for your expertise.
